Gayer Charles K
- SEC CIK
- 0001800110
No open-market purchases or sales filed in the past year.
Current role at each company
- BCRX Biocryst Pharmaceuticals IncPresident and CCOas of Dec 23, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gayer Charles K as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2024 (view filing) | May 13 | 2 days | Gayer Charles KChief Commercial Officer | PPurchase | +30.0K | $5.47 | +$164.1K | +10.8%307.5K after | |
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Gayer Charles KChief Commercial Officer | SSale | −6.10K | $10.90 | −$66.5K | −2.8%211.6K after |